NCT00727558

Brief Summary

This study seeks to evaluate the clinical performance of a new CE marked daily disposable contact lens that contains a wetting agent to a recently improved daily disposable contact lens.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
248

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2008

Shorter than P25 for not_applicable

Geographic Reach
1 country

19 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2008

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

July 30, 2008

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 4, 2008

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2008

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

February 18, 2010

Completed
Last Updated

May 21, 2015

Status Verified

May 1, 2015

Enrollment Period

3 months

First QC Date

July 30, 2008

Results QC Date

September 24, 2009

Last Update Submit

May 5, 2015

Conditions

Keywords

refractive error

Outcome Measures

Primary Outcomes (2)

  • Overall Comfort

    Single question: Comfort scale: 0=N/A, 1=Poor, 2=Fair, 3=Good, 4=Very Good, 5=Excellent

    at 1 week of wear.

  • Measured Limbal Hyperemia

    Measurement of redness of the limbus, graded using half-grade increments using the following scale: 0=none, 1=trace, 2=mild, 3=moderate, 4=severe.

    at 1 week of wear.

Secondary Outcomes (5)

  • Overall Handling

    at 1 week of wear

  • How Comfortable Eyes Feel at the End of the Day

    at 1 week wear

  • End of Day Comfort

    at 1 week of wear

  • Initial Comfort

    at 1 week

  • Inferior Region Corneal Staining

    at 1 week of wear

Study Arms (2)

narafilcon A

ACTIVE COMPARATOR

spherical soft contact lens worn as a daily disposable modality for one week

Device: narafilcon A

nelfilcon A

ACTIVE COMPARATOR

spherical soft contact lens worn as a daily disposable modality for one week

Device: nelfilcon ADevice: narafilcon A

Interventions

spherical soft contact lens

nelfilcon A

spherical soft contact lens

narafilcon Anelfilcon A

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • They are of legal age (18 years) and capacity to volunteer.
  • They understand their rights as a research subject and are willing to sign a Statement of Informed Consent.
  • They are willing and able to follow the protocol.
  • They would be expected to attain at least 6/9 (20/30) in each eye with the study lenses.
  • They are able to wear contact lenses with a back vertex power of -1.00 to -6.00DS.
  • They have a maximum of 1.00D of refractive astigmatism (i.e. ≤ 1.00 DC).
  • They have successfully worn contact lenses within six months of starting the study.

You may not qualify if:

  • They have an ocular disorder which would normally contra-indicate contact lens wear.
  • They have a systemic disorder which would normally contra-indicate contact lens wear.
  • They are using any topical medication such as eye drops or ointment.
  • They are aphakic.
  • They have had corneal refractive surgery.
  • They have any corneal distortion resulting from previous hard or rigid lens wear or has keratoconus.
  • They are pregnant or lactating.
  • They have grade 2 or greater of any of the following ocular surface signs: corneal oedema, corneal vascularisation, corneal staining, tarsal conjunctival changes or any other abnormality which would normally contraindicate contact lens wear.
  • They have any infectious disease (e.g. hepatitis) or any immunosuppressive disease (e.g. HIV).
  • They have diabetes.
  • They have taken part in any other clinical trial or research, within two weeks prior to starting this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (19)

Ellis & Killpartrick

Bath, Bath, BA1 1BA, United Kingdom

Location

Simon Donne Opticians 3-4

Bedford, Bedfordshire, MK40 1NS, United Kingdom

Location

Brock & Houlford

Brislington, Bristol, BS4 3LJ, United Kingdom

Location

The Contact Lens Centre

Plymouth, Devon, PL1 1LB, United Kingdom

Location

Keith Tempany Opticians

Broadstone, Dorset, BH18 8DH, United Kingdom

Location

Eyecare

Ilford, Essex, IG1 4DU, United Kingdom

Location

Leightons Opticians

Albans, Herts, AL1 3LH, United Kingdom

Location

Hazel Smith Opticians

Shanklin, Isle of Wight, PO37 6JZ, United Kingdom

Location

Bowden & Lowe

Gillingham, Kent, ME7 2YX, United Kingdom

Location

David Gould Opticians

Rawtenstall, Lancashire, BB4 7QN, United Kingdom

Location

Vision Express Optical Lab

Hendon, London, NW4 3FB, United Kingdom

Location

Hawkes & Wainer

London, London, EC3V 1LT, United Kingdom

Location

City Opticians

London, London, WC2A 1AA, United Kingdom

Location

David H Burns BSC, FCOptom

Tottenham, London, N17 0EY, United Kingdom

Location

First Contact Opticians

Eastcote Pinner, Middlesex, HA5 1RJ, United Kingdom

Location

Tompkins Knight & Son

Northampton, Northampton, NN2 7BL, United Kingdom

Location

Chalmers & Son (Opticians)

Cardiff, South Glamorgan, CF24 3RQ, United Kingdom

Location

Susan R Bowers Opticians

Coventry, West Midlands, CV4 9DU, United Kingdom

Location

Viewpoint

York, York, YO1 8BA, United Kingdom

Location

MeSH Terms

Conditions

MyopiaRefractive Errors

Condition Hierarchy (Ancestors)

Eye Diseases

Results Point of Contact

Title
Kurt Moody OD, FAAO/ Director
Organization
Vistakon

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 30, 2008

First Posted

August 4, 2008

Study Start

July 1, 2008

Primary Completion

October 1, 2008

Study Completion

October 1, 2008

Last Updated

May 21, 2015

Results First Posted

February 18, 2010

Record last verified: 2015-05

Locations